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Establishment and development    
There has been an allergy clinic at Red Cross Children’s 
Hospital from the day that the doors opened 50 years ago. This 
may not appear surprising given the prevalence of allergic 
conditions in children, but even today few major teaching 
hospitals in South Africa have paediatric allergy clinics – this 
despite the recent International Study of Asthma and Allergies 
in Children (ISAAC) which ranked South Africa twelfth in 
prevalence out of the 56 countries surveyed.1
 Dr Lorn Shore, who had trained in allergy at St Mary’s 
Hospital in London, was instrumental in establishing the clinic. 
He developed an extensive knowledge of local allergens and 
developed and adapted skin-prick test solutions for these 
allergens. He collaborated closely with scientists at the Bencard 
Allergy Unit in the UK producing locally relevant pollen 
allergens. He established that few, if any, indigenous tree and 
weed pollens were allergenic and that allergenic pollens were 
largely derived from imported trees such as oaks and planes. 
Invasive species in the Western Cape such as the Port Jackson 
and pine trees were non-allergenic.
Shore was a most astute clinician. At several postgraduate 
lectures he described the typical progression of allergic 
conditions from atopic eczema to asthma in infants and young 
children which he called ‘standing in the queue for asthma’. 
This phenomemon is now known as the ‘atopic march’ and 
is the subject of worldwide interest and research. He was a 
pioneer in the field of sublingual immunotherapy in children, 
which he used with great success. There has been intense 
international interest and research recently into this method of 
immunotherapy now known as SLIT.
 Shore was a personal friend of Roger Altounyan, the 
discoverer of cromoglycate, the first preventative medication 
used in asthma treatment. Cromoglycate had an enormous 
impact on asthma research leading to the recognition of the 
inflammatory nature of the condition. Shore took part in the 
first studies of the use of cromoglycate in children and was 
later to be involved in the first international studies on the 
use of the pioneer inhaled corticosteroid, beclomethasone, in 
children.
Shore observed that beta2-agonists, notably fenoterol, could 
be absorbed from the buccal mucous membrane in children, 
resulting in effective bronchodilatation. He developed a simple 
clinical test to determine wheezing in infants and young 
children, which he called the ‘squeeze test’. This test involved 
a slight squeeze of the infant’s chest while auscultating during 
expiration.
In 1971 the first full-time consultant was appointed to 
the Allergy Clinic when Eugene Weinberg returned from a 
Fellowship in Paediatric Allergy in the USA. Allergy clinical 
services and research expanded rapidly and the clinic soon 
gained national and international recognition. Initial research 
was devoted to aerobiological studies of allergenic pollens and 
fungi in Cape Town, which continues to this day under the 
supervision of Dilys Berman. Sampling techniques established 
the major importance of house-dust mites as indoor allergens 
in Cape Town. Early studies on the use of a wide-range of 
important drugs used in allergy and asthma treatment were 
conducted. Among these were non-sedating antihistamines, 
inhaled corticosteroids, cromolyns, beta-agonists, theophyllines 
and anticholinergics. Reports of the findings of these studies 
appeared in national and international peer-reviewed 
publications.
Weinberg’s clinical research interests were directed at 
developing appropriate diagnostic and treatment methods 
for children with asthma and allergies. The recognition that 
few Xhosa children were attending the Allergy Clinic in the 
early years despite forming a significant part of Cape Town’s 
population, led to the prevalence studies that have been a 
feature of research in this unit. Urban-rural comparative 
studies on asthma prevalence in Xhosa children2 have led to 
important findings regarding factors responsible for the rapid 
increase in asthma prevalence in children.
In 2001 the Allergy Clinic moved to superb premises in 
the new specialist outpatients building. For the first time 
consultants could work in individual offices and an excellent 
treatment room, patient waiting area, education room, 
laboratory and nurses office became available.
Cas Motala was appointed as the second fulltime consultant 
in the clinic in 1988 and took over as head of the clinic when 
Eugene Weinberg retired in 2004.
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Allergy training and research
The Allergy Clinic at Red Cross Children’s Hospital was the 
first of its kind in southern Africa to provide postgraduate 
training in allergy to senior paediatric registrars – to date, 
seventeen paediatric registrars have been trained. This training 
post in allergy is highly sought after in view of the importance 
of allergic conditions in paediatric practice, particularly in the 
diagnosis and management of asthma, allergic rhinitis, food 
allergies, drug allergies, atopic dermatitis and chronic urticaria. 
The clinic also provides training in venom immunotherapy and 
more unusual allergic and immunological diseases including 
mastocytosis and hereditary angioedema.
Special attention is focused on history taking, aerobiology, 
allergy diagnostic tests (skin-prick tests, in vitro allergy tests, 
lung function tests, food challenges) and the principles of 
management in allergy (environmental control, elimination 
diets, pharmacotherapy, immunotherapy, patient education). 
Specific training is also provided for evaluation and 
management of anaphylaxis.
In addition to ‘clinical’ training, the registrars learn research 
methodology (including writing grant proposals, seeking 
ethical approval, designing studies, conducting research, 
statistical analysis, presentation of data at congresses and 
writing papers). The projects are either stand-alone studies or 
undertaken in collaboration with other units at the hospital 
e.g. Paediatric Pulmonology and Dietetics departments, 
Allergology Unit (Groote Schuur Hospital) and the UCT Lung 
Institute. Many projects have been successfully completed and 
published either as theses or papers.  
One of the notable projects was the development and 
evaluation of low-cost spacer devices for inhaled asthma 
therapy.3,4 The impact of these studies has enabled the use of 
inhaled therapy for asthmatic children and adults in poorly 
resourced areas. Spacer devices are now widely used in 
under-resourced areas and have become the standard of care 
for delivery of inhaled asthma medicines in many parts of 
South Africa. Recommendations for making and use of this 
device appear in the South African Guideline for Treatment of 
Childhood Asthma,5 in the National Guidelines of Integrated 
Management of Childhood Illness (IMCI) and have been 
included in international guidelines for asthma treatment 
including those produced by the World Health Organisation 
(WHO) and the Global Initiative for Asthma (GINA).
Other key studies conducted at the clinic include: (i)
the role of Staphylococcus aureus in eczema; (ii) genetic and 
environmental influences on cord blood serum IgE and an 
atopic sensitisation in infancy; (iii) the requirements for 
hydration in children with acute asthma; (iv) continuous 
monitoring of aerobiology data in the Western Cape; (v)
strategies for treatment of house-dust mite allergy; (vi) cytokine 
profiles in Xhosa children with atopic asthma; (vii) prevalence 
of latex allergy in health care workers; and (viii) autoantibodies 
in children with chronic urticaria.
Future role
The estimated prevalence of allergy and asthma in the 
paediatric population of South Africa is between 10% and 15% 
but is expected to rise with increasing urbanisation.6 Advances 
in the understanding, diagnosis, prevention and treatment of 
allergy are increasing exponentially. Therefore, it is very likely 
that South Africa will need a greater work-force with expertise 
in allergy to manage these disorders. Opportunities for allergy 
training in South Africa remain limited and allergy is still not 
recognised as a specialty. In line with the current emphasis on a 
‘primary health care approach’ in our country, it is essential to 
integrate primary and secondary/tertiary care for allergy and 
asthma.
To meet some of these challenges, we have identified 
five strategic and key issues to shape the future of the 
clinic and the discipline of allergy in sub-Saharan Africa: (i)
promoting education and information of allergy and asthma 
at undergraduate and post graduate levels; (ii) strengthening 
links with primary and secondary level care facilities and 
providing outreach support for management of allergy and 
asthma; (iii) fostering and dissemination of locally relevant 
allergy research; (iv) building strategic alliances with other 
institutions (national and continental departments who 
share a common interest (e.g. pulmonology, dermatology 
and otolaryngology) in the areas of education, training and 
research; and (v) motivation for recognition of paediatric 
allergy as a subspecialty by the Health Professions Council of 
South Africa.
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